Sex-based differences in chronic total occlusion management and long-term clinical outcomes

Eduardo Josué Flores-Umanzor1, Pedro L Cepas-Guillen1, Guillem Caldentey2

  • 1Cardiology Department, Cardiovascular Institute, Hospital Clinic, University of Barcelona, Spain.

Insights

Female sex is linked to worse outcomes in chronic total occlusion (CTO) management. Women with CTO face higher mortality rates and are less likely to receive optimal treatment, highlighting a significant sex disparity in cardiovascular care.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Coronary artery disease (CAD) exhibits known sex differences in presentation and outcomes.
  • Chronic total occlusion (CTO) represents a complex subset of CAD with unique management challenges.

Purpose of the Study:

  • To investigate and compare sex-based disparities in the management of CTO.
  • To evaluate long-term clinical outcomes in relation to sex and CTO treatment strategies.

Main Methods:

  • Retrospective analysis of 1248 consecutive patients diagnosed with CTO between 2010 and 2014.
  • Data collection included demographics, clinical characteristics, and treatment strategies (Medical Therapy alone vs. other).
  • All-cause and cardiac mortality were assessed over a median follow-up of 4.03 years.

Main Results:

  • Women (16%) were older, had higher rates of type 2 diabetes, and lower ejection fraction than men.
  • Despite higher rates of severe ischemia, women were more frequently treated with medical therapy (MT) alone (57% vs. 51%).
  • Female sex was an independent predictor of higher cardiac mortality (HR 1.67) and all-cause mortality, irrespective of treatment.

Conclusions:

  • A significant sex disparity exists in CTO treatment and long-term outcomes.
  • Female sex is an independent risk factor for adverse cardiac events in CTO patients.
  • Further research is warranted to elucidate the mechanisms behind these observed sex differences and to optimize management strategies for women with CTO.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
259
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
163
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.0K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
134